Dr Antonin Descampe
Remark: This page is not a homepage! It lists only the activities of the ISPGroup member mentioned above (e.g., his/her research, project, seminars, ...)
ImagX Research Group: iMagX is a joint project between UCL (Université catholique de Louvain, Belgium) and IBA, world leader in proton therapy. Our interdisciplinary R&D team of 20 engineers, computer scientists, physicists and PhDs, works at the intersection of the scientific, clinical and industrial worlds, in order to create innovative imaging solutions to improve cancer treatment in proton therapy and radiotherapy.
- InVivo Dose Guided Therapy
- The project aims to shift from Image Guided Proton Therapy (IGPT) to Dose Guided Proton Therapy (DGPT) so as to allow the visualisation and quantification of the dose delivered to a patient through simulation (Monte Carlo and analytical) and various means of measurement (CBCT, prompt gamma, time-resolved dosimetry...).
- In-vivo Image Guided Therapy
- In Vivo Image Guided Therapy (Technologies nouvelles d'imagerie médicale appliquées à la thérapie et en particulier à la proton thérapie), SPW/PPP, responsable: Benoît Macq